Simplex Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-132
Closed -$56 10624
2022
Q4
$0 Sell
132
-184
-58% -$60 ﹤0.01% 10935
2022
Q3
$0 Buy
316
+279
+754% +$96 ﹤0.01% 11300
2022
Q2
$0 Sell
37
-26,875
-100% -$11.1K ﹤0.01% 11554
2022
Q1
$18K Buy
26,912
+15,997
+147% +$13.6K ﹤0.01% 8383
2021
Q4
$14K Sell
10,915
-21,321
-66% -$37.8K ﹤0.01% 8781
2021
Q3
$87K Hold
32,236
﹤0.01% 6820
2021
Q2
$88K Buy
32,236
+11,972
+59% +$29.8K ﹤0.01% 6921
2021
Q1
$52K Sell
20,264
-17,599
-46% -$49.8K ﹤0.01% 6583
2020
Q4
$105K Sell
37,863
-10,381
-22% -$30.2K ﹤0.01% 5401
2020
Q3
$222K Buy
48,244
+40,657
+536% +$134K ﹤0.01% 3973
2020
Q2
$21K Sell
7,587
-2,420
-24% -$7.76K ﹤0.01% 6202
2020
Q1
$24K Sell
10,007
-22,123
-69% -$79.9K ﹤0.01% 5811
2019
Q4
$164K Sell
32,130
-32,917
-51% -$183K ﹤0.01% 3972
2019
Q3
$420K Buy
+65,047
New +$449K ﹤0.01% 2790
2019
Q2
Sell
-1,882
Closed -$14.3K 8042
2019
Q1
$20K Buy
1,882
+499
+36% +$4.97K ﹤0.01% 5734
2018
Q4
$11K Sell
1,383
-121
-8% -$1.75K ﹤0.01% 5805
2018
Q3
$29K Sell
1,504
-6,787
-82% -$124K ﹤0.01% 5681
2018
Q2
$149K Buy
8,291
+6,855
+477% +$101K ﹤0.01% 3825
2018
Q1
$15K Sell
1,436
-989
-41% -$15.9K ﹤0.01% 3659
2017
Q4
$102K Buy
2,425
+1,102
+83% +$49.4K ﹤0.01% 1790
2017
Q3
$72K Sell
1,323
-2,715
-67% -$458K ﹤0.01% 1986
2017
Q2
$749K Sell
4,038
-405
-9% -$71K 0.03% 473
2017
Q1
$531K Buy
4,443
+2,274
+105% +$238K 0.02% 645
2016
Q4
$215K Buy
+2,169
New +$228K 0.01% 1006
2015
Q4
Sell
-1,225
Closed -$159K 6350
2015
Q3
$126K Buy
+1,225
New +$144K 0.01% 1236

Other funds holding SIOX

Simplex Trading's SIOX Position: Q1 2023 in Review

Simplex Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 132 shares — an estimated $56 sold.

Simplex Trading first reported a position in SIOX in Q3 2015 and held it in 25 quarters. The position peaked at $749K in Q2 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Simplex Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 132 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $56.
  • Simplex Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 25 quarters.
  • Simplex Trading's Sio Gene Therapies Inc. Common Stock position peaked at $749K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.